REFERENCES
- Cameron K. R., Birchall S. M., Moses M. A. Isolation of foamy virus from patient with dialysis encephalopathy. Lancet 1978; 2: 796
- Drachman D. B. Myasthenia gravis. New England Journal of Medicine 1994; 330: 1797–1810
- Drachman D. B. Myasthenia gravis. In N. Rose and I. Mackay (Eds.), The autoimmune diseases3rd. Academic Press, New York 2002; 637–662
- Glover D. M. DNA cloning. A practical approach3rd. IRL Press, Oxford and Washington 1998
- Hooks J. J., Gibbs C. J., Jr. The foamy viruses. Bacteriological Review 1975; 39: 169–185
- Kasakov V. S., Demidchik E. P., Astakhova L. N. Thyroid cancer after Chernobyl. Nature 1992; 359: 21
- Kuzmenok O. I., Potapnev M. P., Potapova S. M., Smolnikova V. V., Rzheutsky V. A., Yarilin A. A., Savino W., Belyakov I. M. Late effect of Chernobyl radiation accident on T cell-mediated immunity in cleanup workers. Radiation Research 2003; 159: 109–116
- Lagaye S., Vexiau P., Morozov V., Guenebaut-Claudet V., Tobaly-Tapiero J., Canivet M., Cathelineau G., Peries J., Emanoil-Ravier R. Human spumaretrovirus-related sequences in the DNA of leukocytes from patients with Graves disease. Proceedings of the National Academy of Science USA 1992; 89: 10070–10074
- Lindstrom J. M., Seybold M. E., Lennon V. A., Whittingham S., Duane D. D. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates and diagnostic value. Neurology 1976; 26: 1054–1059
- Lochet M., Zentgraf H. W., Flugel R. M. Construction of an infectious DNA clone of the full-length human spumaretrovirus genome and mutagenesis of the bel1 gene. Virology 1991; 184: 43–54
- Meiering C. D., Linial M. L. Historical perspective of foamy virus epidemiology and infection. Clinical Microbiology Reviews 2001; 14: 165–176
- Oger J., Kaufman R., Berry K. Acetylcholine receptor antibodies in myasthenia gravis: Use of a qualitative assay for diagnostic purposes. Canadian Journal of Neurological Sciences 1987; 14: 297–302
- Osserman K. E., Genkins G. Studies in myasthenia gravis: Review of a 20 year experience in over 1200 patients. Mt. Sinai Journal Medicine 1971; 38: 497–537
- Ponomareva E. N., Goncharov A. A., Kuzmenok O. I. Myasthenia Gravis in the Republic of Belarus. Proceeding of the eighth annual meeting of the Russian Society for Multiple Sclerosis, St.-Petersburg, Russia. 1999
- Potapnev M. P., Kuzmenok O. I., Potapova S. M., Smolnykova V. V., Myslistky V. F., Rzheutsky V. A., Vasylevskaya T. A., Vasjuhina L. V. Evaluation of “liquidators” T cell immunity 10 years post Chernobyl accident. Doklady of the National Academy of Sciences of Belarus 1998; 42: 109–112
- Rosai J., Sobin L. H. Histological typing of tumors of the thymus: International histological classification of tumours2nd. New York 1999; 1–65, Springer. World Health Organization
- Saib A., Canivet M., Giron M. L., Bolgert F., Valla J., Lagaye S., Peries J., de the Hugues H. Human foamy virus infection in myasthenia gravis. The Lancet 1994; 343: 666
- Schweizer M., Turek R., Hahn H, Schliephak A., Neitzer K. O., Eder G., Reinhardt M., Rethwilm A., Neumann-Haefekin D. Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: Appropriate testing fails to confirm suspected foamy virus prevalence in humans. AIDS Research and Human Retroviruses 1995; 11: 161–170
- Shibata Y., Yamashita S., Masyakin V. B., Panasyuk G. D., Nagataki S. 15 years after Chernobyl: New evidence of thyroid cancer. Lancet 2001; 358: 1965–1966